Results for tag: "Pomalyst"

Pomalyst (pomalidomide) is a prescription medication used to treat multiple myeloma, a type of cancer that affects the bone marrow. It is a type of immunomodulatory drug (IMiD) that works by blocking the growth of cancer cells and stimulating the body's immune system to fight the cancer. It is usually used in combination with other treatments such as chemotherapy and radiation therapy. Pomalyst is approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma in adults who have received at least two prior therapies. Pomalyst is part of a larger market of leukemia drugs, which includes other IMiDs, monoclonal antibodies, and targeted therapies. These drugs are used to treat various types of leukemia, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL). Some companies in the leukemia drug market include Celgene Corporation, Novartis, Bristol-Myers Squibb, and Pfizer. Show Less Read more